by ICR-Web | Oct 7, 2020 | Studies and testing
Sjögren’s syndrome is a serious autoimmune disease that can cause serious eye and vision problems due to reduced tear production. A phase I trial with direct injection of ASCs into the lacrimal gland has proven safety and efficacy. Based on these data the first...
by ICR-Web | Oct 1, 2020 | Collaborations
Cell2Cure, as part of the consortium Clinical Stem cell Innovation and production Center, CSIC, receives funding from Innovation Fund Denmark. CSIC embraces late-stage development of ASCs – it aims to mature process knowledge and product quality as a...
